AI assistant
MEDICLIN AG — Earnings Release 2013
May 3, 2013
280_rns_2013-05-03_ba681500-862d-456c-a5fd-6e8fd39c8d7a.html
Earnings Release
Open in viewerOpens in your device viewer
News Details
Corporate | 3 May 2013 09:00
MediClin AG: Quarterly Group result below previous year’s value – the Management Board
MediClin AG / Key word(s): Quarter Results
03.05.2013 / 09:00
Quarterly Group result below previous year’s value – the Management Board still focusses on the expansion of indication with strong growth
Offenburg, May 3rd, 2013 – In the first three months of FY 2013 MEDICLIN Aktiengesellschaft (MediClin) has achieved Group sales of EUR 124.5 mill. (Q1 2012: EUR 125.4 mill.) and was therefore EUR 0.9 mill. or 0.7 % below the figure of the first quarter 2012. The quarterly comparison showed sales in the post-acute segment of EUR 70.7 mill. at the same level as last year. In the acute segment sales was EUR 49.6 mill., which was EUR 1.0 mill. below the value of 2012 (Q1 2012: EUR 50.6 mill.). The business area nursing care reports with EUR 3.3 mill. an EUR 0.1 mill. higher sales.
On a quarterly comparison mainly increased personnel costs due to an increase in number of staff and higher material costs could not be compensated by higher sales therefore the Group operating result was EUR -5.9 mill. (Q1 2012: EUR -0.8 mill.). The segment result post-acute was EUR -4.2 mill. (Q1 2012: EUR -1.7 mill.) and in the acute segment EUR 0.1 mill. (Q1 2012: EUR 2.4 mill.) was achieved.
The quarterly result attributable to the shareholders of MediClin accounts for EUR -6.5 mill. (Q1 2012: EUR -2.0 mill.). The un-/diluted earnings per share were EUR -0.14 Euro (Q1 2012: EUR -0,04) for the first three months of 2013
On Group level compared to the previous year’s quarter the number of nursing days decreased from 631,013 days to 607,309 days (-3.8 %) and the number of cases from 30,513 cases to 29,154 Fälle (-4.5 %), in which the number of nursing days in the acute segment slightly increased and in the business area nursing care stayed on a high level nearly unchanged.
In the first three months of 2013 about EUR 4.8 mill. (Q1 2012: EUR 6.5 mill.) were invested in fixed assets (brutto). Another EUR 4.2 mill. (Q1 2012: EUR 4.0 mill.) were spent for service and maintenance. As of March 31, 2013 cash and cash equivalents were EUR 10.0 mill. (31.12.2012: EUR 22.9 mill.) and the equity ratio was 48.1 % (31.12.2012: 49.1 %).
MediClin employed on average 6,352 employees, calculated on the basis of full-time staff, in the first quarter of 2013, 197 employees more than on average in the first quarter of 2012.
Outlook
The Management Board continues the restructuring measures, started midyear 2012, to align the clinics to the changing market conditions. The decrease in occupancy at the turn of the year could be stopped. The current occupancy has already reached the level of the previous year.
MediClin will invest in medical areas, which promise an increase in demand. The demand for medical services is significantly influenced by the demographic development and its requirements.
As regards to the business development of the current financial year, the outlook given so far will retain at this juncture.
The interim report as of March 31, 2013 will be available in German and English from May 15, 2013 under www.mediclin.de.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,100 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,500 employees.
MediClin ─ a company of the Asklepios Group.
End of Corporate News
03.05.2013 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MediClin AG |
| Okenstraße 27 | |
| 77652 Offenburg | |
| Germany | |
| Phone: | +49 (0)781 488-189 |
| Fax: | +49 (0)781 488-184 |
| E-mail: | [email protected] |
| Internet: | www.mediclin.de |
| ISIN: | DE0006595101 |
| WKN: | 659510 |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart |
| End of News | DGAP News-Service |
| - - - |
| 209551 03.05.2013 |